SQSTM1/p62 Knockout by Using the CRISPR/Cas9 System Inhibits Migration and Invasion of Hepatocellular Carcinoma
Cells · 2023
DOI: 10.3390/cells12091238 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Jinghua Lu und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemical Oncogenomics, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Sequestosome-1 Protein. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shenzhen Science and Technology Program, State Key Laboratory of Chemical Oncogenomics Shenzhen International Graduate School, Tsinghua University.
Abstract (Originalsprache)
Migration and invasion play crucial roles in the progression of hepatocellular carcinoma (HCC), but the underlying mechanisms are not clear. Analysis of clinical samples indicates that SQSTM1/p62 is highly expressed in HCC and seriously affects the prognosis of patients. Subsequently, we showed that SQSTM1/p62 knockout using the CRISPR/Cas9 system led to impaired migration and invasion of HCC, upregulated Keap1, and promoted the inhibitory effect of Keap1 on Nrf2. Then, the inactivation of Nrf2 inhibited the expression of matrix metalloproteinases (MMPs), thus attenuating the migration and invasion of HCC. We also found that SQSTM1/p62 knockout significantly inhibited migration and invasion in a lung metastasis model of nude mice with HCC. Furthermore, we found that cisplatin not only significantly inhibited the expression of SQSTM1/p62 but also slowed down the migration and invasion of HCC, while the inflammatory microenvironment accelerated the migration and invasion of HCC. These results suggest for the first time that SQSTM1/p62 knockout inhibits the migration and invasion of HCC through the Keap1/Nrf2/MMP2 signaling pathway. SQSTM1/p62 may be developed into a key drug target to regulate the migration and invasion of HCC cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Chemical Oncogenomics, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China.
- Shenzhen Key Laboratory of Health Science and Technology, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China.
- Institute for Ocean Engineering, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China.
ORCID-Profile: Jin Zhou, Yaou Zhang, Weidong Xie
Förderung
- Shenzhen Science and Technology Program
- State Key Laboratory of Chemical Oncogenomics Shenzhen International Graduate School, Tsinghua University
Zitieren
APA
Lu, J., Ding, Y., Zhang, W., Qi, Y., Zhou, J., Xu, N., Zhang, Y., & Xie, W. (2023). SQSTM1/p62 Knockout by Using the CRISPR/Cas9 System Inhibits Migration and Invasion of Hepatocellular Carcinoma. Cells. https://doi.org/10.3390/cells12091238
Vancouver
Lu J, Ding Y, Zhang W, Qi Y, Zhou J, Xu N, et al. SQSTM1/p62 Knockout by Using the CRISPR/Cas9 System Inhibits Migration and Invasion of Hepatocellular Carcinoma. Cells. 2023. doi:10.3390/cells12091238
BibTeX
@article{Lu2023,
author = {Lu, Jinghua and Ding, Yipei and Zhang, Wanqiu and Qi, Yuanyuan and Zhou, Jin and Xu, Naihan and Zhang, Yaou and Xie, Weidong},
title = {SQSTM1/p62 Knockout by Using the CRISPR/Cas9 System Inhibits Migration and Invasion of Hepatocellular Carcinoma},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12091238}
}
EUVIMED